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Aims It is well established that dysfunction of voltage-dependent ion channels results in arrhythmias and conduction
disturbances in the foetal and adult heart. However, the involvement of voltage-insensitive cationic TRPC (transient
receptor potential canonical) channels remains unclear. We assessed the hypothesis that TRPC channels play a
crucial role in the spontaneous activity of the developing heart.
Methods
and results
TRPC isoforms were investigated in isolated hearts obtained from 4-day-old chick embryos. Using RT-PCR, western
blotting and co-immunoprecipitation, we report for the first time that TRPC1, 3, 4, 5, 6, and 7 isoforms are expressed
at the mRNA and protein levels and that they can form a macromolecular complex with the a1C subunit of the
L-type voltage-gated calcium channel (Cav1.2) in atria and ventricle. Using ex vivo electrocardiograms, electrograms
of isolated atria and ventricle and ventricular mechanograms, we found that inhibition of TRPC channels by SKF-
96365 leads to negative chrono-, dromo-, and inotropic effects, prolongs the QT interval, and provokes first- and
second-degree atrioventricular blocks. Pyr3, a specific antagonist of TRPC3, affected essentially atrioventricular
conduction. On the other hand, specific blockade of the L-type calcium channel with nifedipine rapidly stopped
ventricular contractile activity without affecting rhythmic electrical activity.
Conclusions These results give new insights into the key role that TRPC channels, via interaction with the Cav1.2 channel, play in
regulation of cardiac pacemaking, conduction, ventricular activity, and contractility during cardiogenesis.
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1. Introduction
Intracellular calcium signalling plays an important role in the cardiac
physiology and development.1 In the adult mammalian myocardium,
depolarizing current resulting in a relatively small calcium influx
across the sarcolemma contributes to the initiation of action potential
in atrial pacemaker cells or to the plateau phase in ventricular myo-
cytes. This entry is followed by a further calcium release from the sar-
coplasmic reticulum (SR) via a mechanism termed Ca2+-induced Ca2+
release, which leads to contraction, the so-called excitation–contrac-
tion (EC) coupling.2 However, in the mammalian embryo/foetus,
calcium appears to come exclusively through sarcolemmal calcium
influx because of immature SR.3
In contrast, in the embryonic chick heart, all the components
necessary for a functioning SR and EC coupling are expressed early
such as ryanodine receptor (RyR2), SR Ca2+-ATPase (SERCA2), L-
and T-type voltage-dependent calcium channels, and Na+/Ca2+
exchanger.4 –8 Additionally, Brotto and Creazzo have estimated in
the embryonic chick heart that 70% of the calcium available for the
transient comes through sarcolemmal calcium channels, while the
remainder is from SR calcium release.7
The traditional view of the electrical and contractile activities of the
developing and adult heart is the result of cooperative activity of series
of sarcolemmal voltage-dependent channels generating spontaneous
action potentials and subsequently muscle contraction (as reviewed
in DiFrancesco9). It becomes clear that cyclical release of Ca2+ from
SR stores occurs in pacemaker cells and that IP3R- or RyR-mediated
calcium release has a novel role in regulating cardiac pacemaker activity
during early development.10,11 Preliminary reports suggest that another
pathway involving TRPC (transient receptor potential canonical)-
dependent calcium entry related to SR Ca2+ depletion and to
receptor-coupled phospholipase C (PLC) activation contributes to
pacemaker activity in adult toad and mouse pacemaker node.12,13
The membrane subfamily of TRPC channels, composed of seven
members (TRPC1-7), is thought to assemble as homo- or hetero-
tetramers to form non-selective cation channels permeable to Na+
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and Ca2+. TRPC channels contribute in a widespread number of non-
excitable and excitable cells to non-voltage-dependent cation entry
with many physiological roles or pathological consequences. They
are activated (i) in response to G-protein receptor stimulation
through PLC signalling by IP3 or by diacylglycerol referred to
receptor-operated channels,14,15 (ii) by depletion of internal calcium
stores referred to SOCs (store-operated channels),16 and (iii) in
response to increased membrane stretch termed stretch-activated
channels.17 In addition to conventional SOCs, calcium entry called
excitation-coupled Ca2+ entry (ECCE) through dihydropyridines
receptor (DHPR)/TRPC channels initiated by membrane depolariz-
ation has been reported in skeletal muscle.18,19
The identification of TRPC channels was a new starting point in the
search for their function in skeletal muscle (as reviewed in Sabourin
et al.20) and their involvement in cardiovascular function and heart diseases.
All TRPC isoforms, excepted TRPC5, are expressed in the adult
mouse heart21,22 and a tight control of calcium homeostasis has
been attributed to SOCs in neonatal and adult cardiomyocytes.23,24
Indeed, uncontrolled TRPC-dependent calcium entry is involved in
the development of cardiac hypertrophy and failure (as reviewed in
Eder and Molkentin25), dilated cardiomyopathy, muscular dystrophy,
and arrhythmogenesis.26– 28
In light of the growing evidence linking TRPC channels to normal
function of adult cardiomyocytes, we first examined TRPC genes
and proteins expression during cardiogenesis. We assessed the
crucial role played by TRPC channels in the spontaneous activity of
the 4-day-old embryonic chick heart model, free of extrinsic inner-
vation, and neurohumoral influences. The present study shows for
the first time that TRPC channels play a key role in regulation of pace-
making, conduction, and contractility in the developing heart.
2. Methods
2.1 Experimental model
Fertilized eggs from Lohman Brown hens were incubated during 96 h at
388C and 95% relative humidity to obtain stage 24HH embryos (according
to Hamburger and Hamilton, 1951) corresponding to embryonic Day 4
(ED4). Hearts were carefully excised from embryos and dissected to
isolate the whole heart or to separate atria from ventricle with outflow
tract in place to limit tissue injury.
2.2 Reagents and antibodies
Nifedipine [L-type calcium channel (LCC) inhibitor], SKF-96365
(1-[b-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenethyl]-1H-imidazole
hydrochloride, 1-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]
ethyl]imidazole named SKF, TRPC channels inhibitor), Pyr3 (inhibitor of
TRPC3), and CPA (SR Ca2+-ATPase inhibitor) were from Sigma-Aldrich
(Sigma-Aldrich, Buchs, Switzerland). Rabbit polyclonal antibodies used
against TRPC1, 3, 4, 5, 6, and Cav1.2 were from Alomone (Alomone labs,
Jerusalem, Israel). Goat polyclonal anti-TRPC7 was from Everest Biotech
(Everest Biotech, Oxfordshire, UK). The rabbit polyclonal antibody
against GAPDH was from Abcam (Abcam, Cambridge, UK). Secondary anti-
bodies for western blot were horseradish peroxidase-conjugated donkey
anti-rabbit IgG (GE healthcare, Glattbrugg, Switzerland) and horseradish
peroxidase-conjugated donkey anti-goat IgG (Santa cruz Biotechnology,
Inc., Heidelberg, Germany). Purified Goat and Rabbit IgG were from
Sigma-Aldrich.
2.3 Western blot
Embryonic hearts were dissected into atria, ventricle, and outflow tract. In
brief, samples were denatured, 30 mg protein was loaded per lane, separ-
ated on SDS–polyacrylamide gels, and transferred to nitrocellulose mem-
branes. Membranes were blocked and probed overnight with antibodies
against TRPC1, 3, 4, 5, 6, 7, and Cav1.2 or GAPDH. A control fusion
protein was used as control antigen. After washes, the membranes
were incubated with the secondary anti-rabbit or anti-goat IgG. Immuno-
reactive bands were detected with enhanced chemiluminescent pro-
cedure. See Supplementary material online for detailed methods.
2.4 Co-immunoprecipitation
After lysis, 2 mg of antibody was added to a volume of lysates containing
300 mg of atrial or ventricular proteins diluted with NET solubilization
buffer and incubated at 48C overnight with constant mixing. Then, the
protein–antibody complex was incubated with Protein A Sepharose.
The immune complexes were collected by centrifugation and washed in
NET. After denaturing, samples were subjected to SDS–PAGE. See Sup-
plementary material online for detailed methods.
2.5 PCR amplification
Messenger RNA isolation from embryonic heart tissue was performed
using the RNeasy Plus Mini kit. RT-PCR was conducted using SuperScript
III one-step RT-PCR with platinum Taq in a Biometra TRIO-thermoblock.
See Supplementary material online for detailed methods.
2.6 Ex vivo mounting of the heart
Spontaneously beating hearts or isolated atria and ventricle were placed in
the culture compartment of a stainless steel airtight chamber maintained
at 37.58C as described elsewhere in detail.29 See Supplementary material
online for detailed methods.
2.7 Recording of electrical and contractile
activities
ECG, atrial and ventricular electrograms (EG), and apical shortening of the
ventricle were recorded simultaneously and continuously throughout ex
vivo experiments as previously described.29 See Supplementary material
online for detailed methods.
2.8 Experimental protocol
Once mounted in the chamber, the hearts were first stabilized during
45 min under normoxia at 37.58C. Then, the medium was replaced by
the vehicle using remote-controlled push–pull syringes, in order to
assess a possible unspecific effect of the vehicle perfusion on cardiac
activity. In the control group, only the medium/vehicle was introduced.
Time ‘0’ is the time point just before introduction of the pharmacological
agents. ECG, EG, and ventricular shortening were continuously recorded
throughout all experiments.
The experimental protocol is represented below.
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2.9 Statistical analysis
All values are reported as mean+ SEM. The non-parametric Mann–
Whitney test was used for dose–response curves of SKF and calcu-
lation of QTc. The significance of any difference between two
groups was assessed with one-way repeated measures ANOVA com-
pleted by Tukey’s post hoc test for ECG, EG, and contractile exper-
iments. The statistical significance was defined by a value of P, 0.05
(*P, 0.05; **P, 0.01; ***P, 0.001).
3. Results
3.1 Expression of TRPC genes and proteins
in the embryonic heart
We used RT-PCR to examine mRNA expression of the seven known
mammalian TRPC isoforms in the embryonic chick heart (ED4). We
used TRPC subunit PCR products that were initially validated and
confirmed by sequencing in embryonic (ED8) chick retina RNA, a
tissue known to express all TRPC isoforms except TRPC2, which is
expressed only in mice.30 TRPC1, 3, 4, 5, 6, and 7 transcripts were
detected in the whole heart as well as in retina (Figure 1A).
Antibodies raised against TRPC1, 3, 4, 5, 6, and 7 were used to evalu-
ate by western blot the expression of these proteins in the embryonic
heart. TRPC1, 3, 4, 5, 6, and 7 proteins were expressed in atria, ventricle
and outflow tract (Figure 1B). The densitometric analysis of the TRPCs
normalized to GAPDH showed that each TRPC isoform was expressed
at the same level in atria and ventricle (see Supplementary material
online, Figure S1). For each TRPC isoform, a fusion protein was used
as control antigen. Anti-TRPCs antibodies were preincubated with
their relevant antigens for negative control (see Supplementary
material online, Figure S2A). Moreover, immunoprecipitation for each
isoform was performed showing a band corresponding to respective
Figure 1 Genes and proteins expression of TRPC isoforms in the embryonic chick heart (ED4) and retina (ED8). (A) TRPC1, TRPC3-7 mRNAs
were identified by RT-PCR. PCR products of the predicted sizes for the different TRPC species were between 150 and 950 bp. b-Actin was amplified
as a positive control. The negative control [ctrl(2)] contained water instead of DNA. (B) TRPC1, TRPC3-7 proteins are all expressed in atria,
ventricle, and outflow tract (n ¼ 3–4). GAPDH was used as a control of equal loading of proteins.
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TRPC isoforms at the same molecular weight as in total lysates (see
Supplementary material online, Figure S2B).
3.2 Dose–response for SKF-96365 (SKF),
the traditional inhibitor of TRPC channels
SKF is widely used as a blocker of TRPC channels (as reviewed in
Putney31). Measurement of beating rates and detection of manifest
arrhythmias were performed by visual observation in plastic wells 20
or 40 min after addition of SKF (Figure 2A–C ). Figure 2A shows that con-
centrations higher than 5 mM of SKF induced arrhythmias (atrioventri-
cular blocks and cardioplegia) in whole hearts with an IC50 of 10.3 mM as
determined using the Hill equation (see Supplementary material online,
Figure S3A). It should be noticed that 15% of control untreated hearts
showed spontaneous arrhythmias but none was arrested in this group.
The intrinsic beating rate of the untreated isolated atria and ventricle
was 168+6 b.p.m. (n ¼ 29) and 65+6 b.p.m. (n ¼ 29), respectively,
and remained stable during at least 1 h. In non-arrested atria and ventri-
cle, the atrial and ventricular spontaneous beating rate were progress-
ively reduced and increased by SKF, respectively, in a dose-dependent
manner (Figure 2B). The dose-dependent and time-dependent effects
of SKF on activity of isolated atria and ventricle are presented in
Figure 2C and D, respectively. Atria and ventricle showed a differential
sensitivity to TRPC inhibition since SKF at 40 mM arrested 81% of the
ventricles and only 36% of the atria after 20 min (Figure 2C). The IC50
for SKF determined in atria and ventricles from the dose–response
curves obtained after 40 min was 25.3 and 8.7 mM, respectively (see
Supplementary material online, Figure S3B). Figure 2D shows that SKF
at 40 mM stopped ventricle more rapidly than atria, whereas neither
control atria nor ventricles were arrested.
3.3 Interaction between TRPC channels
and a1C subunit of the L-type calcium
channel (LCC)
Both TRPC channels and LCC were partially inhibited by SKF (10 mM)
and nifedipine (NIF 50 nM), respectively, at concentrations which,
when administrated alone, did not alter significantly atrial rate.
Figure 3A shows that atrial firing rate decreased by 62% after 20 min
when SKF was combined with NIF compared with treatment with
NIF or SKF alone suggesting a synergetic effect. It should be men-
tioned that the combined treatment not only reduced atrial beating
rate, but also markedly increased incidence of arrhythmias and cardi-
oplegia (Figure 3B), strongly suggesting a functional interrelation
between these two types of channels.
Furthermore, the formation of a complex between TRPC channels
and the a1C subunit of LCC was explored in the developing heart
because it has been established that TRPC3 channel is required for
full gain EC coupling via their association with DHPR and RyR in adult
skeletal muscle.19
Figure 3C represents immunoblots revealed by Cav1.2 antibody in
atria and ventricle. A band of 240 kDa, corresponding to a1C
subunit of LCC, was detected in the anti-TRPC1, anti-TRPC3,
anti-TRPC4, anti-TRPC5, anti-TRPC6, and anti-TRPC7 precipitates.
Conversely, immunoblots revealed by TRPC1 and TRPC3-7 anti-
bodies detected bands of 110, 95, 100, 110, 120, and 95 kDa
Figure 2 Effect of TRPC channels inhibition on cardiac function. (A) Dose–response curve of SKF in whole hearts after 20 min (n ¼ 19–76). (B)
Dose–response curves of isolated atria and ventricles that were non-arrested by SKF after 20 min. 0 mM, control with the vehicle; b.p.m., beats per
min; *P, 0.05 vs. 0 mM (n ¼ 6–29). (C) Dose–response curves of isolated atria and ventricles treated 20 min (solid lines) or 40 min (dotted lines)
with SKF (n ¼ 17–33). (D) Time-dependent effect of SKF 40 mM on atrial and ventricular activities; ctrl, controls of atria and ventricle in vehicle
(n ¼ 17–33).
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corresponding to the molecular weight of TRPC1, 3, 4, 5, 6, and 7,
respectively, with anti-Cav1.2 precipitates (Figure 3D). These results
clearly show that endogenous TRPC1 and TRPC3-7 may form mul-
tiple complexes with the endogenous a1C subunit of Cav1.2
channel in atria and ventricle.
3.4 Involvement of TRPC and L-type
calcium channels (LCC) in cardiac
electrical activity
We explored the contribution of TRPC channels to electrical
activity of the developing heart. The effect of SKF, Pyr3, a specific
blocker of TRPC3,32 or NIF was determined on atrial and ventricu-
lar beating rate, atrioventricular conduction (PR interval),
ventricular activity (QTp duration), and intra-ventricular conduction
(QRS complex width). We focused on the 15 min time point at
which SKF had the most pronounced effect on cardiac activity.
Additionally, various types of arrhythmias were identified. It
should be noticed that the corresponding vehicle had no effect
on the electrical parameters of the whole heart, isolated atria, or
ventricle for at least 60 min (not shown). The important changes
in ECG and EG morphology induced by SKF, Pyr3, and NIF are
illustrated in Figure 4 and the altered functional parameters
reported in Table 1.
In six out of seven experiments, inhibition of TRPC channels by SKF
induced rapidly and transiently (during the first 15 min) second-
degree atrioventricular blocks, essentially in the form of Mobitz
type I (Wenckebach phenomenon) characterized by a progressive
Figure 3 (A–B) Synergetic effects of SKF and NIF on arrhythmias. (A) Time dependency of beating rate of hearts treated with SKF (10 mM) or
nifedipine (NIF 50 nM) alone or combined. b.p.m., beats per min (n ¼ 12–34). (B) Histogram showing the synergetic and detrimental effect of
SKF combined with NIF after 60 min (% of arrhythmic or arrested hearts). (C–D) All isoforms of TRPC channels formed a macromolecular
complex with Cav1.2 in the embryonic heart. (C ) Lysates (input lane) from atria and ventricles were incubated with antibodies against TRPC1 and
TRPC3-7. Western blots of the immunoprecipitated proteins were probed with antibody against Cav1.2; PAS, Protein A Sepharose. (D) Lysates
from atria and ventricle were incubated with antibodies against TRPC1, TRPC3-7, and Cav1.2. Western blots of the immunoprecipitated proteins
were probed with antibodies against all TRPC proteins.
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lengthening of the PR interval followed by a dropped QRS without
alteration of the atrial rhythm (Figure 4A). This episode of Wencke-
bach phenomenon was followed by first-degree atrioventricular
block characterized by a prolonged PR interval (+27%) and a mark-
edly increase in QTp duration by 35% (Table 1). The temporal
pattern of ECG morphology under control conditions and in the pres-
ence of SKF showed clearly the significant prolongation of PR and
QTp intervals induced by TRPC inhibition throughout 60 min (see
Supplementary material online, Figure S4A and S4B).
Pyr3 also induced immediately and transiently Wenckebach
phenomenon in all experiments (n ¼ 4; Figure 4B) but, in contrast
to SKF, had no additional effect on the measured parameters.
The prolongation of QTp induced by inhibition of TRPC channels
was confirmed in isolated ventricle (Figure 4C; Table 1). Moreover,
SKF widened significantly the QRS complex after 15 min, suggesting
a reduction in intra-ventricular conduction (Table 1).
Importantly, exposure of isolated ventricle to SKF in combination
with NIF (2 mM) prevented the SKF-induced lengthening of QTp
(Table 1), suggesting that LCC were overactivated. Moreover, SKF
combined with NIF did not prevent the SKF-induced widening of
QRS complex (Table 1). This last result suggests that the regulation
of intra-ventricular conduction is dependent on TRPC channels.
High concentration of SKF (40 mM) reduced significantly the
beating rate of whole heart and isolated atria at 15 min (Figure 4D;
Figure 4 Representative ECG recordings showing the P, QRS and T components of the embryonic heart spontaneously beating ex vivo treated with
SKF 40 mM (A) or Pyr3 10 mM (B). SKF and Pyr3 provoked the same type of arrhythmia: Mobitz type I second-degree atrioventricular block. Repre-
sentative electrograms of isolated ventricle (C) and atria (D) before and after 15 min treatment with SKF 40 mM. (E) Ventricular electrogram before
and after 15 min treatment with NIF 2 mM.
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Table 1). On the contrary, SKF had a positive chronotropic effect on
isolated ventricle (Figure 4C; Table 1).
The QT interval corrected for heart rate (QTc) was calculated with
Bazett’s formula. SKF increased significantly QTc of whole hearts
(+15%) and isolated ventricles (+76%), indicating an increased risk
of ventricular arrhythmias when TRPC channels are inhibited
(Table 1).
SKF is usually identified as a selective blocker of TRPC channels but
recently, two reports suggest that SKF can also inhibit L- and T-type
calcium channels (TCC).33,34 Thus, to validate the specific effect of
SKF on TRPC channels, we performed the same experiments in iso-
lated ventricle with LCC and TCC inhibitors, NIF, and mibefradil,
respectively. As expected, inhibition of LCC with NIF 2 mM induced
a progressive and significant shortening of QTp (Figure 4E) and had
no effect on QRS width (Table 1). Additionally, mibefradil 2 mM tran-
siently decreased QTp duration by 17% (before mibefradil, 107+
11 ms; +mibefradil (5 min), 89+8 ms; n ¼ 5; ***P, 0.001; see Sup-
plementary material online, Figure S5) suggesting a minor role of TCC
in spontaneous electrical activity of the embryonic chick heart. Thus,
these results show that NIF, mibefradil, and SKF have distinct targets
according to their distinct effects on QTp duration and QRS width.
SKF inhibits essentially TRPC channels according to the results.
3.5 Involvement of TRPC and L-type
calcium channels (LCC) in myocardial
contractility
In order to investigate the relative contribution of LCC and TRPC
channels to ventricular contractility, EG and shortening of isolated
ventricle were recorded simultaneously in the presence of NIF or
SKF as shown in Figure 5A and B. The specific contribution of
TRPC3 to ventricular contractility was also explored in whole heart
with the specific inhibitor, Pyr3 (Figure 5C). SKF (40 mM) and NIF
(2 mM) had a negative inotropic effect (Figure 5A, B, and D),
whereas Pyr3 (10 mM) had no effect on ventricular shortening
(Figure 5C and D), suggesting that TRPC3 isoform is not involved in
contractility.
NIF progressively prolonged the ventricular electromechanical
delay (reflecting the EC coupling) after 5 min [before NIF, 16.0+
0.8 ms; +NIF (5 min), 25.1+ 1.9 ms; n ¼ 3; **P, 0.01] and finally
suppressed ventricular shortening within 35 min (Figure 5A and D),
whereas SKF reduced shortening by 31% after 5 min and 50% after
60 min (Figure 5B and D). Interestingly, contractile activity was abol-
ished by NIF, whereas a spontaneous and regular electrical activity
persisted (Figure 5A). Such a permanent electromechanical dis-
sociation indicates that pacemaking mechanisms in the ventricular car-
diomyocytes were not significantly affected by blockade of LCC,
whereas the contraction mechanism is strongly dependent on LCC.
Inhibition of TRPC channels by SKF altered neither ventricular elec-
tromechanical delay [before SKF, 18.1+0.8 ms; n ¼ 6; +SKF
(5 min), 17.1+0.9 ms; n ¼ 6; +SKF (60 min), 17.9+1.5 ms; n ¼ 3]
nor contraction to relaxation shortening velocities ratio [before
SKF, 1.18+ 0.05; n ¼ 6; +SKF (5 min), 1.09+ 0.05; n ¼ 6; +SKF
(60 min), 1.12+0.07; n ¼ 5].
4. Discussion
4.1 Involvement of TRPC channels in atrial
pacemaking and atrioventricular
conduction
We found for the first time that TRPC1, 3, 4, 5, 6, and 7 are expressed in
atria, ventricle, and outflow tract of the developing chick heart, which
suggests a functional role of these isoforms. Indeed, the traditional
inhibitor of TRPC channels, SKF, slowed pacemaker firing rate in the
whole heart or isolated atria, supporting a role for TRPC channels in
atrial pacemaker function. These observations raise the possibility
that inward current (Na+ and Ca2+) through TRPC channels can influ-
ence pacemaking rate as suggested in neurons, interstitial cell of Cajal,
rat cardiomyocytes, and pacemaker cells.12,22,35– 37 These channels, as
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Table 1 Functional parameters before (vehicle) and after 15 min of SKF 40 mM and NIF 2 mM alone or combined
Vehicle SKF NIF SKF 1NIF
Pacemaker
Beating rate (b.p.m.) Whole heart 162+13 (5) 106+15 * (5) ND
Isolated atria 190+15 (3) 137+11 * (3) ND
Isolated ventricle 49+3 (6) 64+3 *** (6) —
46+6 (4) — 58+6 (4)
Conduction
PR interval (ms) Whole heart 117+9 (5) 148+13 * (5) ND
Duration of electrical activation
QTp duration (ms) Whole heart 105+5 (5) 142+4 ** (5) ND
Isolated ventricle 94+6 (6) 141+10 *** (6) —
94+7 (4) — 59+1 *** (4)
115+4 (4) 142+10 *** (4) — 110+5 (4)
QTc value (ms) Whole heart 268+7 (4) 308+12 * (4)
Isolated ventricle 136+10 (6) 240+15 * (6)
QRS width (ms) Isolated ventricle 11.4+0.9 (6) 19.2+1.2 *** (6) —
10.0+1.3 (4) — 11.1+1.7 (4)
9.6+1.2 (4) 17.9+2.1 * (4) — 20.3+2.3* (4)
( ), number of hearts, isolated atria, or ventricles investigated.
*P, 0.05, **P, 0.01, ***P, 0.001 vs. vehicle.
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SOCs, may also be modulated by fluctuations of Ca2+ SR stores during
each cardiac cycle. Indeed, depletion of Ca2+ SR stores either by acti-
vation of RyR with ryanodine 10 nM5 or by inhibition of the SR Ca2+-
ATPase with CPA (see Supplementary material online, Figure S6) had
a positive chronotropic effect in our model. Moreover, partial inhibition
of TRPC channels with SKF 5 mM prevented the CPA-induced tachycar-
dia, which strongly supports the concept that TRPC channels act as
SOCs (Figure 6A).
The interesting finding that all TRPC channels formed multiple com-
plexes with the a1C subunit of Cav1.2 channel can be explained by the
fact that distinct TRPC subunits can associate to form heterotetramers,
increasing the probability that all TRPC isoforms interacted with Cav1.2
channel. Thus, the voltage-independent TRPC channel may form a func-
tional unit with Cav1.2 channel, this complex being sensitive to mem-
brane depolarization (Figure 6A) in a manner comparable with ECCE
observed in skeletal muscle.18 Furthermore, our findings that inhibition
of TRPC channels prolonged PR interval and induced mainly Wencke-
bach phenomenon clearly indicate that these channels play a crucial
role in atrioventricular conduction. This suggests that cell membrane
excitability and/or gap junction communication could be strongly
altered in the embryonic myocardium in the case of TRPC dysfunction.
Supporting the hypothesis of a role of TRPC channels in conduction,
recent studies demonstrate a functional link between Cx43 protein
and TRPC1 in S1P-differentiating myoblasts and a relationship
between Cx43 and TRPC3 function in ovine uterine artery endothelial
cells.38,39 Our findings that the specific inhibition of TRPC3 by Pyr3, as
well as inhibition of all TRPC channels by SKF, induced essentially
Wenckebach phenomenon strongly suggest that TRPC channels and
especially TRPC3 can be involved in conduction disturbances. Hence,
these channels may represent potential pharmacological targets in
order to reduce arrhythmias arising from propagation disturbances.
Interestingly, the rhythm and conduction disturbances induced by
Figure 5 Representative simultaneous recordings of ventricular electrogram (VEG) and apical shortening (S) after 5 and 35 min exposure to NIF (A)
and SKF (B) showing negative inotropic effect (n ¼ 3–6). (C ) The absence of the effect of Pyr3 10 mM on ventricular shortening (n ¼ 4). (D) Time-
dependent effects of NIF 2 mM, Pyr3 10 mM, and SKF 40 mM on ventricular shortening (n ¼ 3–6). The shortening is expressed as per cent of the
respective control value; ctrl, vehicle.
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inhibition of TRPC channels in our model correspond well to sinus bra-
dycardia, first-degree and second-degree atrioventricular blocks
observed in the suffering foetal human heart (as reviewed in Strasburger
and Wakai40 and Sonesson41).
4.2 Involvement of TRPC channels in
ventricular electrical activity
The possibility that spontaneous and rhythmic activity of the isolated
ventricle was essentially attributable to LCC can be ruled out since
NIF abolished contraction without affecting EG. As expected, NIF
also reduced QTp interval reflecting a shortening of the plateau dur-
ation of the action potential in ventricular myocytes.
On the contrary, inhibition of TRPC channels led to the pro-
longation of QTp interval, widening of QRS complex and ventricular
tachycardia. A longer QTc is known to put adult heart at an increased
risk for ventricular arrhythmias; it seems also to be the case in the
embryonic heart at stage 24HH when TRPC channels are inhibited.
Interestingly, ventricular arrhythmias induced by inhibition of TRPC
channels in our model correspond well to ventricular tachycardia
and long QT syndrome observed in the suffering foetal human
heart (as reviewed in Strasburger and Wakai40).
Figure 6 Model based on the present findings illustrating the regulation of electrical and mechanical activities by TRPC and Cav1.2 channels in atria
and ventricle of the developing heart. (A) TRPC channels can act as SOCs and can form a functional unit with voltage-sensitive Cav1.2 channel, gen-
erating inward current and contributing to diastolic depolarization during spontaneous atrial beat. (B) Ventricular electrical activity is controlled by the
macromolecular complex TRPC/Cav1.2, where TRPC channels, directly or indirectly, negatively regulate Cav1.2 activity. (C) Cav1.2 channel predo-
minantly contributes to calcium transient for contraction, whereas TRPC channels play a role in refilling continuously the modest calcium stores of the
SR. C, C-terminal; ECCE, excitation-coupled Ca2+ Entry; ext, exterior; int, interior; IP3R, inositol 1,4,5-triphosphate receptor; N, N-terminal; RyR,
ryanodine receptor; SERCA, sarco/endoplasmic reticulum Ca2+-ATPase; SOCE, store-operated Ca2+ Entry; SR, sarcoplasmic reticulum; TRPC, tran-
sient receptor potential canonical.
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SKF acted selectively on TRPC channels and not on LCC or TCC
since NIF and mibefradil instead reduced QTp interval and had no
effect on the QRS and ventricular beating rate. The prolongation of
the QT interval could result from increased inward LCC current as
described in human type 8 Long QT syndrome (as reviewed in
Hedley et al.42). Similarly, the ventricular tachycardia associated with
prolonged QT interval and widened QRS, which finally led to
arrest, could be related to LCC-dependent calcium overload as
shown in the human and mouse heart model.43,44 Indeed, we
showed that the prolongation of QT interval is predominantly due
to LCC activity since exposure to SKF and NIF in combination
reversed the effect of SKF alone on QTp interval (Table 1).
However, NIF did not prevent the SKF-induced QRS widening,
which seems to be independent of LCC. Thus, TRPC channels may
play a direct role in the control of intra-ventricular conduction as
well as in atrioventricular conduction as discussed already.
Co-immunoprecipitation experiments demonstrated that all
TRPC channels interact with the a1C subunit of the Cav1.2
channel in the ventricle. Additionally, TRPC channels are known
to be regulatory elements for other channels forming macromolecu-
lar complex such as cystic fibrosis transmembrane conductance reg-
ulator in airway epithelial human cells and BKCa potassium channel
in vascular smooth muscle cells.45,46 These observations lead to the
proposal that TRPC channels act as elements regulating negatively
Cav1.2 channel by a direct or indirect interaction (Figure 6B).
Indeed, calcium entry through TRPC channels may lead to Ca2+
accumulation in subsarcolemmal area close to Cav1.2 channel con-
trolling the Ca2+-dependent inactivation of Cav1.2 channel. Thus,
the inhibition of TRPC channels by SKF could induce conformational
changes in the ionic pore structure of Cav1.2 channel and/or could
delay Ca2+-dependent inactivation of the a1C subunit leading to its
overactivation and cellular Ca2+ overload.
4.3 Modulation of ventricular contractility
by TRPC channels
Ca2+-free medium rapidly suppresses most of contractions of the
embryonic chick heart indicating that contraction depends largely
on extracellular Ca2+ influx. It is also well known that TRPC channels
participate to contraction activity in smooth muscle and mesangial
cells.47–49
Our findings show for the first time that specific blockade of LCC
by NIF stopped contractions in the developing heart but did not affect
ventricular electrical activity, revealing an electromechanical dis-
sociation, whereas inhibition of TRPC channels by SKF diminished
only partially the myocardial shortening. In contrast, Pyr3 inhibiting
exclusively TRPC3 channel had no effect on contraction, suggesting
that, at least, this TRPC isoform may not be involved in contractility
of the embryonic myocardium. Thus, the Ca2+ transient necessary
for contraction depends essentially on Ca2+ entry through LCC.
TRPC channels, acting as cationic channels independently of LCC,
may have a complementary role in preventing rapid depletion of
the modest Ca2+ SR stores of the embryonic heart. This mechanism
could provide a continuous store refilling during repetitive electrome-
chanical activity ensuring Ca2+ homeostasis and optimal EC coupling
gain (Figure 6C). Recently, it has been shown that TRPC1 channel
modulates Ca2+ entry during repeated muscle contractions and
allows mouse skeletal muscle to maintain force production during sus-
tained stimulations and cope with fatigue.50
4.4 Conclusion
Our findings indicate that, in the developing chick heart, which pos-
sesses an early and highly complex calcium signalling network, LCC
and TRPC channels appear to form a functional macromolecular
complex capable of subtle and efficient regulation of pacemaking gen-
eration and conduction. Furthermore, Ca2+ transient triggering myo-
filaments interaction may depend predominantly on LCC with a
complementary role for TRPC channels to refill the relatively
limited sarcoplasmic Ca2+ stores and insure the sustained cardiac
activity of the embryo.
The types of arrhythmias provoked by TRPC channels inhibition in
our model are also observed in the suffering foetal human heart.
Despite such similarities, there is a limitation to translate findings
from one species to another. However, in the context of the
recent advances in foetal cardiology, our experimental data give
new insights into the underlying mechanisms of the dysfunction of
the developing heart, a rather unexplored but promising domain.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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